Finnadvance is bridging the gap between in-vitro and in-vivo research with its microfluidic organ-on-chips for pharmaceutical drug research and development. With industry leading high throughput microphysiological culture platforms, complex in vivo biomechanical cues are mimicked on the in vitro cultures.
- Founding year:
- Development phase:
- Funding stage:
- Website:
- Contact person info:
- Team members:
- Article:
2019
Market-ready
A round
science(at)finnadvance.com
18
Read an article about Finnadvance.
Recent Comments